Author: Abdul-Hafez, Amal; Mohamed, Tarek; Uhal, Bruce D.
Title: Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research Cord-id: zpxz94me Document date: 2021_5_3
ID: zpxz94me
Snippet: Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Like the 2002–2003 epidemic severe acute respiratory syndrome coronavirus (SARS-CoV), angiotensin converting enzyme-2 (ACE-2) has been identified as the SARS-CoV-2 receptor.(1–3) The virus docks into host cell via its spike protein binding to ACE-2 and undergoes proteolytic cleavage by TMPRSS2 protease to facilitate membrane fusion. The spike protein binding to ACE-2 has been sh
Document: Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Like the 2002–2003 epidemic severe acute respiratory syndrome coronavirus (SARS-CoV), angiotensin converting enzyme-2 (ACE-2) has been identified as the SARS-CoV-2 receptor.(1–3) The virus docks into host cell via its spike protein binding to ACE-2 and undergoes proteolytic cleavage by TMPRSS2 protease to facilitate membrane fusion. The spike protein binding to ACE-2 has been shown to be stronger in the novel SARS-CoV-2 virus.(1) This review will present an overview of ACE-2 biology.
Search related documents:
Co phrase search for related documents- acceptable safety profile and liver disease: 1, 2
- acceptable safety profile and lung disease: 1, 2
- acceptable safety profile and lung fibrosis: 1
- acceptable safety profile and lung function: 1
- ace angiotensin convert enzyme and acute respiratory syndrome: 1
Co phrase search for related documents, hyperlinks ordered by date